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A B S T R A C T
Diﬀerentiation of umbilical cord blood derived mononuclear cells to endothelial cells is accompanied by massive
changes in gene expression. Although methylation and demethylation of DNA likely play crucial roles in reg-
ulating gene expression, their interplay during diﬀerentiation remains elusive. To address this question, we
performed deep sequencing of DNA methylation and mRNA expression to proﬁle global changes in promoter
methylation and gene expression during diﬀerentiation from mononuclear cells to outgrowing cells. We iden-
tiﬁed 61 downregulated genes with hypermethylation, including CD74, VAV1, TLR8, and NCF4, as well as 21
upregulated genes with hypomethylation, including ECSCR, MCAM, PGF, and ARHGEF15. Interestingly, gene
ontology analysis showed that downregulated genes with hypermethylation were enriched in immune-related
functions, and upregulated genes with hypomethylation were enriched in the developmental process and an-
giogenesis, indicating the important roles of DNA methylation in regulating diﬀerentiation. We performed
polymerase chain reaction analyses and bisulﬁte sequencing of representative genes (CD74, VAV1, ECSCR, and
MCAM) to verify the negative correlation between DNA methylation and gene expression. Further, inhibition of
DNA methyltransferase and demethylase activities using 5′-aza-dc and shRNAs, speciﬁc for TET1 and TET2
mRNAs, respectively, revealed that DNA methylation was the main regulator of the reversible expression of
functionally important genes. Collectively, our ﬁndings implicate DNA methylation as a critical regulator of gene
expression during umbilical cord blood derived mononuclear cells to endothelial cell diﬀerentiation.
1. Introduction
Umbilical cord blood derived mononuclear cells (UCB-MNCs) could
be diﬀerentiated to the endothelial lineage (Asahara et al., 1997;
Eggermann et al., 2003). The phenotypes of UCB-MNC derived out-
growth endothelial cells (OECs) such as proliferative potential, migra-
tion, and tube formation, are similar to those of other endothelial cell
(EC) types such as LECs, HUVECs, and HUAECs (Medina et al., 2010a;
Patan, 2004). Diﬀerentiation of circulating UCB-MNCs is associated
with altered global gene expression. In particular, fully diﬀerentiated
UCB-MNCs downregulate the expression of stem cell antigens such as
CD34 and CD133 and increase the expression markers of mature ECs
such as CD31, KDR, vWF, and e-NOS (Hristov et al., 2003). Recent
studies indicate that altered chromatin organization can aﬀect cell type-
speciﬁc gene expression by changing the accessibility of genes to
transcription factors in either a positive or a negative manner (Voss and
Hager, 2014). Two major classes of such modiﬁcations include DNA
methylation and histone methylation, acetylation, or both. DNA me-
thylation is associated with gene silencing (Schubeler, 2015) and reg-
ulates tissue-speciﬁc gene expression (Jones and Takai, 2001; Jaenisch
et al., 1994). In mammalian cells, CpG methylation is catalyzed by a
family of DNA methyltransferase enzymes (DNMTases) comprising
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Dnmt1, Dnmt3a, and Dnmt3b (Hermann et al., 2004; Okano et al.,
1999). In hematopoietic stem cells (HSCs), Dnmt3a-null mice exhibit
the upregulation of HSC multipotency genes and downregulation of
diﬀerentiation genes; further, their progeny exhibit global hypo-
methylation and insuﬃcient repression of HSC-speciﬁc genes (Challen
et al., 2012). Loss of Dnmt3a and Dnmt3b from embryonic stem cells
(ESCs) leads to the loss of diﬀerentiation potential with cell passage,
although the potential for self-renewal is maintained (Chen et al.,
2003). Conversely, DNA demethylation is catalyzed by Ten-eleven
translocation (TET) proteins TET1, TET2, and TET3. These processes
comprise two ways that activate and passive DNA demethylation. TETs
promote DNA demethylation by catalyzing the conversion of methyl-
cytosine (5mC) to 5-hydroxymethylcytosine (5-hmC) or 5-for-
mylcytosine (5-fC) and 5-carboxylcytosine (5-caC) (Bhutani et al.,
2011). In mouse ESCs, TET1 regulates transcription by promoting de-
methylation at CpG sites in promoters and by repressing transcription
through binding to the Polycomb group of target genes (Williams et al.,
2011). Moreover, TET2 plays a role in hematopoiesis by limiting the
self-renewal capacities of HSCs and by regulating diﬀerentiation. Here,
we aimed to determine how promoter DNA methylation regulates gene
expression during UCB-MNC to EC diﬀerentiation (Ko et al., 2010;
Pronier et al., 2011).
By integrating methylated DNA immunoprecipitation-sequencing
(MeDIP-Seq) with RNA-Seq analyses of UCB-MNCs and OECs, we
identiﬁed a signiﬁcant set of genes regulated by DNA methylation
during the diﬀerentiation of UCB-MNCs to OECs. We identiﬁed the
biological functions of these genes and veriﬁed their expression and
methylation patterns. Further, we demonstrated direct regulation of
gene expression through DNA methyltransferase and demethylase. Our
results show that DNA methylation is involved in endothelial lineage-
speciﬁc gene expression, indicating a role for epigenetic mechanisms in
the regulation of the diﬀerentiation of UCB-MNCs to OECs.
2. Materials and methods
2.1. UCB-MNC isolation and sample preparation
UCB-MNCs were isolated from human cord blood using Ficoll-Paque
density gradient centrifugation. Cells were seeded onto six-well plates
coated with ﬁbronectin (Sigma-Aldrich, Inc., St Louis, MO) and cul-
tured in EBM™-2 (Clonetics Cell Systems, St Katharinen, Germany).
Media were supplemented with 20% heat-inactivated fetal bovine
serum (FBS) and EGM™-2 SingleQuots® (Clonetics Cell Systems). After
3 days, nonadherent cells were removed, and fresh culture medium was
added. Cultures were maintained for 30 days. Each sample was pre-
pared for RNA and MeDIP sequencing from ﬁve cord blood samples. In
addition, MNCs and OECs were used from another cord blood sample as
experimental evidence to support our ﬁndings.
2.2. Genomic DNA isolation and methylation sequencing and proﬁling
Genomic DNA was isolated using a NucleoSpin-Tissue Kit
(Macherey-Nagel) and fragmented to a median length of 150 bp using a
Covaris-S2 (Covaris). Methylated DNA was isolated from fragmented,
genomic DNA via binding to the methyl-CpG binding domain of human
MBD2. Libraries were prepared according to the manufacturer's in-
structions (Illumina Chip DNA Prep Kit). Methylated DNA was ampli-
ﬁed using PCR. The libraries were puriﬁed and size-selected using 2%
agarose gel electrophoresis. The puriﬁed products were quantitated
before seeding the clusters in a ﬂow cell of a 2100 Bioanalyzer and
QPCR. Clusters were generated in the ﬂow cell of a cBot automated
cluster generation system (Illumina), and the ﬂow cell was loaded on a
HISEQ 2000 sequencing system (Illumina) that generates 1 × 50-bp
reads. Sequence reads were aligned to the human genome (hg19 from
the UCSC genome database) using BWA (version 0.7.5a) (Li and Durbin,
2009) after a standard quality check and trimming using FastQC and
Fastx-toolkit, respectively. The MEDIPS package (version 1.8.0)
(Chavez et al., 2010) of the BioConductor software project was used to
identify the methylated DNA segments. Speciﬁcally, the targeted data
resolution and the extension range for smoothing were deﬁned as 50 bp
and 400 bp (i.e., bin_size = 50 and extend = 400), respectively. The
mean methylation value is expressed as the relative methylation score
(rms) was obtained for each nonoverlapping window of 500 bp.
2.3. RNA sequencing and analysis
Total RNA was isolated using an RNeasy Kit (Qiagen), and integrity
was checked using an Agilent Technologies 2100 Bioanalyzer using an
RNA Integrity Number (RIN) value > 8. Libraries of mRNA sequences
were prepared using the Illumina Truseq RNA Prep Kit, and mRNA was
puriﬁed (two rounds) and fragmented from total RNA (1 μg) using
oligo-T bound to magnetic beads. RNA sequencing was performed using
an Illumina HiSeq 2000 (101-bp paired-end runs). Sequence reads were
aligned to the human genome reference sequence (hg19 from the UCSC
genome database) using Tophat2 (version 2.0.9) (Kim et al., 2013) after
a standard quality check and trimming using FastQC and Fastx-toolkit
(version 0.0.13.2), respectively. Cuﬄinks (version 2.1.1) (Trapnell
et al., 2012) was used to quantify mRNA abundance. Genes that were
diﬀerentially expressed by UCB-MNCs and OECs were identiﬁed using
edgeR (version 3.0.8) (Robinson et al., 2010), DESeq (version 1.10.1)
(Anders and Huber, 2010), DEGSeq (version 1.12.0) (Wang et al.,
2010), and NOISeq (version 1.1.5) (Tarazona et al., 2015).
2.4. Correlation between DNA methylation and gene expression
To explore the regulatory impact of DNA methylation on gene ex-
pression, statistical tests of enrichment and depletion were performed
for negative and positive correlations between DNA methylation and
gene expression, respectively. The matching numbers of diﬀerentially
methylated and diﬀerentially expressed genes (i.e., 3,279 DMR genes
and 491 DEGs) were randomly selected. Hyper/hypomethylated genes
and up/downregulated genes were selected in a mutually exclusive
manner. Then, the number of genes was counted with negative (hyper-
down and hypo-up) and positive (hyper-up and hypo-down) correla-
tions. This procedure was repeated 100,000 times to estimate the P-
value of the enrichment and depletion of negative and positive corre-
lations in the observed values, respectively.
2.5. Microarray data
UCB-MNC and OEC RNA-Seq data were compared using the pub-
lically available microarray databases Gene Expression Omnibus (GEO)
database (GSE46328 (Kim et al., 2015) and GSE20283 (Medina et al.,
2010b)). Quantile values of gene expression data were normalized and
used to generate heat maps of diﬀerentially expressed genes (DEGs).
2.6. Gene-set analysis
Gene-set analysis of gene ontology (GO) terms was performed using
the WebGestalt web server (Kirov et al., 2014). Two gene sets of up-
regulated DEGs with hypo-methylated DMRs and downregulated DEGs
with hyper-methylated DMRs were included in the analysis to deduce
the functions of the DEGs.
2.7. RNA isolation and RT-PCR analysis
Total RNAs were isolated from UCB-MNCs and OECs using TRIzol
reagent (Invitrogen, Carlsbad, CA). RNA (1 μg) served as template for
cDNA synthesis using M-MLV reverse transcriptase (Promega, Munich,
Germany) according to the manufacturer's instructions. RT-PCR was
performed using Taq polymerase (Intron Biotechnology, Seoul, Korea)
in a reaction mix containing 1× reaction buﬀer, 1.5 mM MgCl2,
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0.2 mM deoxynucleotide mix, 0.5 units Taq polymerase, and 0.2 μM
each forward and reverse primers. The ampliﬁcation conditions were as
follows: 5 min at 95 °C, 30 cycles at 94 °C for 30 s, 55 °C for 30 s, 72 °C
for 1 min, and ﬁnal extension at 72 °C for 10 min. The PCR products
were analyzed using 1.5% agarose electrophoresis.
2.8. Quantitative real-time PCR analysis (qRT-PCR)
The qRT-PCR reactions were performed using the Maxima SYBR
Green/ROX qPCR Master Mix (Thermo Scientiﬁc, Waltham, MA, USA)
with a PikoReal™ Real-Time PCR System (Thermo Scientiﬁc) according
to the manufacturer's recommended protocol. The PCR conditions for
genes were as follows: 5 min at 95 °C, 50 cycles at 94 °C for 10 s, 58 °C
for 20 s, 72 °C for 30 s, and ﬁnal extension at 72 °C for 10 min. All re-
sults were normalized to the levels of human GAPDH mRNA.
2.9. Bisulﬁte sequencing
Genomic DNA (1 μg) was treated with bisulﬁte using the EZ DNA
Methylation-Direction Kit (Zymo Research, Irvine, CA) and then sub-
jected to PCR ampliﬁcation. PCR conditions were as follows: 5 min at
95 °C, 50 cycles at 94 °C for 10 s, 58 °C for 20 s, 72 °C for 30 s, and ﬁnal
extension at 72 °C for 10 min.
OECs were treated at passages 3–5 with 5′-aza-2′-deoxycytidine (5′-
aza-dc) (10 μmol/l) (Sigma-Aldrich) every 24 h for 7 days. Six days
after isolation, UCB-MNCs were treated with 5′-aza-dc (Sigma-Aldrich)
using these same conditions.
2.10. Lentivirus production and infection
TET1-depleted and control cells were generated by transducing the
cells with TET1-shRNA or a scrambled shRNA incorporated into a
pLKO.1 lentiviral particle (Santa Cruz Biotechnology, Inc.). Transduced
OECs were selected and maintained in media containing 1 μg/ml pur-
omycin. Four days later, the TET2-shRNA or control shRNA was used to
transduce TET1-depleted cells. TET1- and TET2-depleted cells were
selected from cultures containing 1 μg/ml puromycin in the medium.
2.11. Statistical analysis
All statistical analyses were performed using Graphpad Prism
(version 5.0; Graphpad Software, La Jolla, CA). Tests for statistical
signiﬁcance were two-sided, and probability values < 0.05 were re-
ﬂected signiﬁcant. The Student's t-test or ANOVA was used to compare
mean values, and results are presented as mean ± SEM or SD.
3. Results
3.1. Integrative proﬁling analysis identiﬁes genes that are diﬀerentially
methylated and expressed in UCB-MNCs and OECs
We previously reported that UCB-MNCs could be diﬀerentiated to
EC lineage. Global gene expression change has been occurred during
diﬀerentiation. Among them, we conﬁrmed mononuclear cell markers,
CD133, CXCR4 and CD45 were decreased as well as endothelial cell
markers, CD31, kinase insert domain receptor (KDR), von-Willebrand
factor (vWF) and VE-cadherin were increased (Kim et al., 2015; Jung
et al., 2010; Maeng et al., 2015). To understand the relationship be-
tween DNA methylation change and gene expression regulation during
UCB-MNC to EC diﬀerentiation, we performed MeDIP sequencing and
RNA sequencing (Fig. 1A). Diﬀerentially methylated regions (DMRs)
were deﬁned as follows: i)> 2-fold change in mean methylation value
(rms ratio > 2 or< 0.5), ii) rms methylation score within the highest
1% of either sample (quant = 0.99) (strong signals only), and iii)
Wilcoxon test, p value < 10−4. To identify DMRs with regulatory
roles, we further ﬁltered DMRs within the promoter regions (−2 kb to
+0.5 kb) of protein coding genes available from UCSC RefSeq genes.
Comparing OECs to UCB-MNCs, we identiﬁed 2180 hypomethylated
regions in 1419 genes and 2694 hypermethylated regions in 1860
genes. DEGs were identiﬁed by considering the intersections of (i)
edgeR (version 3.0.8), p < 0.05; (ii) DESeq (version 1.10.1),
p < 0.05; (iii) DEGSeq (version 1.12.0), absolute log2 fold-change >
2 and q < 10−5, and (iv) NOISeq (version 1.1.5), q > 0.99. This
analysis identiﬁed 203 upregulated and 288 downregulated genes in
OECs compared with UCB-MNCs (Supplementary Fig. 1).
Next, we searched for negative correlations between the gene ex-
pression and DNA methylation data. Taking the intersections of 288
downregulated DEGs and the 1860 hyper-DMRs (Fig. 1B), we identiﬁed
61 downregulated genes with promoter hypermethylation. Similarly,
we obtained 21 upregulated genes with promoter hypomethylation.
Statistical analysis using random simulation showed that these negative
correlations between the gene expression and DNA methylation were
signiﬁcantly enriched with the p-value of 0 and 0.009 for hyper-me-
thylated and hypo-methylated cases, respectively. Depletions in the
positive correlated bins were rather weak. The degree of enrichment/
depletion was higher for downregulated genes, which is likely due to
the fact that promoter DNA methylation typically acts to repress gene
transcription.
Nevertheless, we focused on 82 DEGs with negative correlations
with DMRs (Supplementary Tables 1 and 2), which should represent
candidate genes that may play important roles in the diﬀerentiation of
the endothelial lineage via promoter methylation. We further compared
the expression of these focus genes using independent data sets. Our
RNA-Seq data were highly consistent with the independent microarray
datasets GSE46328 (Kim et al., 2015) and GSE20283 (Medina et al.,
2010b) (Fig. 1C). These temporal data reveal that the expression levels
of the focus genes did not vary signiﬁcantly during the UCB-MNC state
for 13 days and that the changes in expression occurred during terminal
diﬀerentiation, likely through promoter methylation.
3.2. Gene ontology analysis indicates the biological functions of
methylation-dependent genes that are diﬀerentially expressed during
diﬀerentiation into the endothelial lineage
To determine the biological relevance of DEGs through a compar-
ison of DNA methylation between UCB-MNCs and OECs, we subjected
the focus genes to GO using the bioinformatics tool WebGestalt (WEB-
based GEne SeT AnaLysis Toolkit). We analyzed lists of hypermethy-
lated and hypomethylated genes separately. Biological processes en-
riched for 61 downregulated genes with hypermethylation (61 genes)
were mainly associated with immune-related functions, including GO
categories such as “defense response” (GO:0006952) and “immune re-
sponse” (GO:0006952) (Fig. 2A and Supplementary Table 3A). In
contrast, 21 upregulated genes with hypomethylation were enriched in
Fig. 1. Integrative analysis of DNA methylation and gene expression during UCB-MNC to OEC diﬀerentiation. (A) Diagrams describing the proﬁling process for identifying diﬀerentially
methylated and expressed genes in UCB-MNCs and OECs. (B) The overlap of diﬀerentially methylated and expressed genes is shown in the Venn diagram format. Numbers in the
intersection regions are the number of genes satisfying both conditions, p-value of enrichment or depletion (marked as P), and average with standard deviation (marked as R) obtained
from random simulation of 100,000 times. (C) RNA-seq analysis of gene expression proﬁles of UCB-MNC and OEC of our samples (left) and two publicly available microarrays (middle and
right). The expression values of our focus genes are shown by the heat map. Genes are ordered by average linkage hierarchical clustering of the RNA-Seq dataset. The colour gradient of
RNA-Seq and microarrays indicates Fragments Per Kilobase Million (log2 FPKM+ 1) and z-score transformed across samples, respectively. In the heat map, red represents high
expression, blue represents low expression, and gray represents undetectable expression. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the
web version of this article.)
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GO functional terms associated with developmental process
(GO:0032502) and angiogenesis (GO:0001525), which represent the
major roles of ECs (Fig. 2B and Supplementary Table 3B).
GO analysis of molecular functions revealed that hypermethylated
genes were most enriched in MHC and IgG binding associated with the
immune response (Fig. 2C and Supplementary Table 3C). Moreover,
hypomethylated genes were enriched in those encoding guanine nu-
cleotide exchange factors that may play important roles in the mor-
phological changes that occur during diﬀerentiation (Fig. 2D and
Supplementary Table 3D). Thus, highly consistent results were acquired
from analyses of molecular functions and biological processes. More-
over, the GO analysis results are consistent for UCB-MNCs and OECs
derived from cord blood or peripheral blood (Medina et al., 2010b),
indicating that diﬀerentiation is independent of the donor cell type of
origin. Together, the diﬀerentiation from UCB-MNCs to OECs involves
several important changes in biological processes such as the immune
response and inﬂammation (characteristics of UCB-MNCs) and devel-
opmental process and angiogenesis (characteristics of OECs), which are
likely regulated by DNA methylation.
3.3. RT-PCR validation of diﬀerentially expressed genes
We next determined the transcriptional states of focus genes asso-
ciated with changes in promoter methylation. For this purpose, we
conducted RT-PCR analysis to determine whether the RNA-Seq data
reﬂected diﬀerences in expression. The expression of the 61 hy-
permethylated genes was downregulated and the expression of the 21
hypomethylated genes was signiﬁcantly increased in OECs compared
with UCB-MNCs (Supplementary Fig. 2A and B). We used qRT-PCR to
quantitate the changes in expression of randomly selected genes re-
presenting the most enriched GO terms. The expression of genes related
to defense and immune response-related genes CD74, VAV1, TLR8,
LILRB2, ITGAX, NCF4, LGALS3BP, LSP1, TRPM2, and ADAP1 was sig-
niﬁcantly decreased in OECs (Fig. 3A). In contrast, the expression of
developmental process and angiogenesis-associated genes ECSCR, MC-
AM, PGF, ARHGEF15, CLDN11, APLN, MDFI, CTHRC1, DOCK6, and
DOCK9 was signiﬁcantly increased in OECs (Fig. 3B). Therefore, we
conﬁrmed that diﬀerentially expressed genes identiﬁed using RNA-Seq
analysis were diﬀerentially regulated in UCB-MNCs and OECs.
3.4. DNA methylation status reveals a negative correlation of gene
expression with diﬀerentiation
To determine if there was a negative correlation between validated
gene expression and DNA methylation, we used the MeDIP-seq data to
compare the methylation patterns of genes diﬀerentially expressed in
UCB-MNCs compared with OECs (Fig. 4). The genes selected were those
that exhibited the largest changes in DNA methylation between UCB-
MNCs and OECs as well as to reveal their biological functions. CD74,
VAV1, TLR8, NCF4, ITGAX, and LILRB2 were not methylated in OECs at
each CpG site of the proximal promoter region, whereas high levels of
DNA methylation were detected in UCB-MNCs (Fig. 4A). Conversely,
angiogenesis-related upregulated genes expressed by OECs (ECSCR,
MCAM, PGF, ARHGEF15, APLN, and CLDN11) represented a low
Fig. 2. Gene ontology (GO) analysis of signiﬁcant diﬀerentially methylated and expressed genes. Gene ontology analysis using the WebGestalt Bioinformatics Resources was performed to
identify biological processes and molecular functions associated with diﬀerentially expressed genes according to DNA methylation during UCB-MNC to OEC diﬀerentiation (p < 0.05).
(A, B) Highest 10 biological process for hyper- and hypomethylated genes. The most signiﬁcant ontology associated with hypermethylated and downregulated genes is immune system
processes, and the most highly enriched process associated with hypomethylated and upregulated genes is related to development and angiogenesis. (C) The highest 10 molecular
functions of hypermethylated and genes expressed diﬀerentially at lower levels. The most signiﬁcant function is MHC protein binding essential for the immune system. (D) The highest six
molecular functions for hypomethylated and upregulated genes. The most highly enriched molecular function is guanine nucleotide exchange factor activity (GEF) associated with
morphogenesis.
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Fig. 3. Validation of mRNA levels of representative genes enriched GO terms. (A) qRT-PCR analysis of mRNA expression levels of representative hypermethylated genes. (B) Transcript
levels of angiogenesis and developmental process-related hypomethylated genes. The transcript levels were normalized to that of GAPDH mRNA. **p < 0.01, ***p < 0.001 versus UCB-
MNC.
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Fig. 4. Diﬀerential methylation levels of promoters of representative genes at each CpG site. Promoter methylation was determined using MeDIP-Seq results. (A) The promoters of CD74,
VAV1, TLR8, NCF4, ITGAX, and LILRB2 are unmethylated at each CpG site in UCB-MNCs (blue) and densely methylated in OECs (red). However, (B) the promoters of ECSCR,MCAM, PGF,
ARHGEF15, APLN, and CLDN11 are highly methylated in UCB-MNCs and methylated at low levels in OECs. The percentage methylation represents a relative score based on the highest
methylation value. Open circles represent each CpG site. Blue line, UCB-MNC; red line, OEC. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to
the web version of this article.)
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percentage of DNA methylation in OECs at each CpG site compared
with UCB-MNCs (Fig. 4B). These results indicate that hyper- or hypo-
methylation negatively regulates gene expression.
3.5. Bisulﬁte sequencing reveals DNA methylation patterns of representative
genes
To conﬁrm these results of statistical analysis acquired from DNA
methylation sequencing, we performed bisulﬁte sequencing of CD74,
VAV1, ECSCR, and MCAM. CD74 is highly expressed by UCB-MNCs.
Previous expression analysis of peripheral blood-derived eEPCs and
OECs shows that CD74 mediates the immune response (Medina et al.,
2010b) and that VAV1 mediates hematopoiesis (Katzav, 2009). We
selected regions with the largest changes in promoter methylation
(Fig. 5A and B red box). The promoters of CD74 and VAV1 were not
methylated in UCB-MNCs but were densely methylated in OECs
(Fig. 5A). In the hypomethylated dataset, the angiogenesis-related
genes ECSCR and MCAM are closely associated with VEGF signaling,
which mediates EC function (Kilari et al., 2013; Jiang et al., 2012).
Moreover, ECSCR enhances VEGFR2 activation and promotes EC mi-
gration (Verma et al., 2010), and MCAM mediates EC proliferation,
adhesion, and migration (Jiang et al., 2012; Bardin et al., 2001).
Comparison of bisulﬁte sequencing data for UCB-MNCs to OECs reveals
that the ECSCR and MCAM promoters were not methylated in OECs but
were highly methylation in UCB-MNCs (Fig. 5B). Thus, these data
conﬁrm the accuracy of the proﬁling data and indicate that DNA me-
thylation contributes to the alteration of gene expression.
3.6. DNA methyltransferase directly regulates gene expression and
methylation patterns during the diﬀerentiation of UCB-MNCs to OECs
To understand the regulatory mechanism of transcriptional in-
activation mediated by increased promoter methylation, we in-
vestigated the eﬀects of DNA methyltransferases (DNMTases) on epi-
genetically silenced genes in OECs. We ﬁrst determined the expression
levels of DNMT3A, DNMT3B, and DNMT1 in UCB-MNCs and OECs.
Expression of each gene increased in OECs compared with UCB-MNCs
(Fig. 6A), indicating that gain of DNA methylation is more common
than its loss during the diﬀerentiation of mononuclear cells into term-
inally diﬀerentiated cells.
We treated OECs with the DMMT inhibitor 5′-aza-dc and found that
among 61 hypermethylated downregulated genes, the transcription of
genes related to the immune system was reactivated (Fig. 6B). To de-
termine whether reactivation was caused by DNA demethylation, we
performed bisulﬁte sequencing. The methylation of VAV1 was reduced
in 5′-aza-dc-treated OECs (Fig. 6C). The promoter region of the re-
presentative UCB-MNC enriched gene CXCR4 was not methylated in
UCB-MNCs or OECs. Further, CXCR4 expression was unchanged fol-
lowing treated with 5′-aza-dc (Fig. 6B). These ﬁndings suggest that DNA
methylation is not involved in the transcriptional regulation of CXCR4.
Taken together, we conclude that DNMTases regulates DNA methyla-
tion during diﬀerentiation and silence the expression of immune-re-
lated UCB-MNC enriched genes.
3.7. DNA demethylation activates gene expression during the diﬀerentiation
of UCB-MNCs to OECs
We next treated UCB-MNCs with 5′-aza-dc to determine whether
silenced expression of OEC-enriched genes was induced by DNA me-
thylation. The qRT-PCR results show that 5′-aza-dc activated the tran-
scription of the OEC-enriched genes ECSCR, PGF, MCAM, and
ARHGEF15 in UCB-MNCs (Fig. 7A). Thus, increased DNA methylation
induced by DNMTases maintained the silenced expression pattern of
angiogenesis-related genes in UCB-MNCs. Therefore, we sought to ex-
plore the role of DNA demethylase in the activation of silenced genes.
We ﬁrst determined the expression of DNA demethylase family
genes TET1, TET2, and TET3 in UCB-MNCs and OECs. If all TET family
genes were expressed in OECs, TET2 and TET3 expression levels de-
creased. In particular, TET3 was signiﬁcantly reduced compared with
TET2. However, TET1 expression was increased in OECs compared with
UCB-MNCs (Fig. 7B). Therefore, we cotransduced OECs with a lenti-
viruses expressing shRNA targeting TET1 or TET2. Knockdown of TET1
and TET2 reduced the levels of TET1 and TET2 transcripts by 60%
(Supplementary Fig. 3). After knockdown of TET1 and TET2 expression,
qRT-PCR analysis detected decreased expression of the angiogenesis-
related genes ECSCR and PGF and the developmental process-associated
genes MDFI and CTHRC1 and DOCK9 (Fig. 7C). Although VEGFR2 is
highly expressed in OECs and associated with angiogenesis, its me-
thylation did not change during diﬀerentiation. Accordingly, VEGFR2
expression was unchanged in UCB-MNCs treated with 5′-aza-dc or in
OECs cotransduced with TET1 and TET2 shRNAs (Fig. 7C). These results
suggest that DNA methyltransferase and demethylase directly regulate
certain cell type-speciﬁc genes by changing DNA methylation patterns
during UCB-MNC to OEC diﬀerentiation and that they play a role in
maintaining the expression patterns of terminally diﬀerentiated cells.
4. Discussion
In this study, we determined that DNA methylation was signiﬁcantly
involved in regulating UCB-MNC to OEC diﬀerentiation. We used
MeDIP-Seq and RNA-Seq to proﬁle the changes in promoter methyla-
tion and gene expression during the diﬀerentiation of UCB-MNCs to
OECs. We identiﬁed 82 genes that showed negative correlation between
methylation and gene expression.
Functional analysis revealed that the characteristics of UCB-MNCs,
i.e., immune-associated functions, were silenced by hypermethylation
and the characteristics of OECs, such as developmental process and
angiogenesis, were activated with hypomethylation during diﬀer-
entiation. Furthermore, we identiﬁed that DNA methylation regulators
(DNMTases and TETs) directly regulated gene expression through the
reactivation of silenced genes. Our ﬁndings suggest that DNA methy-
lation and demethylation are speciﬁc regulators for determining the
gain and loss of biological function during UCB-MNC to OEC diﬀer-
entiation.
Thus, we provide a new insight that epigenetic mechanisms are
involved in UCB-MNC to OEC diﬀerentiation. Accumulating evidence
shows that DNA methylation plays important roles in regulating gene
expression and cell diﬀerentiation. For example, DNMT3a-deﬁcient
HSCs increase self-renewal by upregulating multipotency genes that are
crucial for HSC functions (Gata3, Runx1, Pbx1, and Cdkn1a) and by
downregulating diﬀerentiation-related genes (Flk2, Sfpi1, and Mef2c)
(Challen et al., 2012). Loss of Dnmt3a and Dnmt3b from HSCs inhibits
proliferative potential, although these cells retain diﬀerentiation po-
tential (Challen et al., 2014). Moreover, the loss of TET2 results in
impaired hematopoietic diﬀerentiation and preferential myeloid com-
mitment (Ko et al., 2010; Figueroa et al., 2010), suggesting that de novo
methylation is important for self-renewal and diﬀerentiation of HSCs.
HSCs are multipotent cells that give rise to erythrocytes, lymphocytes,
monocytes, and granulocytes (Seita and Weissman, 2010). HSCs and
UCB-MNCs are derived from a common precursor (hemangioblast)
(Pardanaud et al., 1989; Flamme and Risau, 1992). In particular, CD31-
and CD34-positive HSCs have similar capacities of diﬀerentiation to EC
Fig. 5. Promoter methylation of immune response- and angiogenesis-related genes. (A–B) Bisulﬁte sequence analysis of speciﬁc CpG promoter sites (red box) proximal to the transcription
start sites of representative genes (CD74, VAV1, ECSCR, and MCAM). Unmethylated CpGs (Open circles), methylated CpGs (ﬁlled circles) of 5 independent CpG clones encompassing the
region of interest. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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lineage (Wijelath et al., 2004; Lian et al., 2014). However, DNA me-
thylation has not been studied in the diﬀerentiation of UCB-MNCs and
HSCs to EC lineage. Our integrative analysis data indicate that epige-
netic mechanisms are involved in UCB-MNC to EC diﬀerentiation and
newly found diﬀerentially methylated and expressed genes in UCB-
MNCs and OECs. Furthermore, this is the ﬁrst study to demonstrate that
representative biological functions of UCB-MNCs or OECs were
regulated by DNA methylation and demethylation. Previous tran-
scriptome proﬁling studies of UCB-MNCs and ECs showed that PB-de-
rived early EPCs are hematopoietic cells with a typical monocyte phe-
notype, are enriched in transcripts involved in inﬂammation and
immune responses, and PB EPC-derived OECs possess angiogenic
properties (Medina et al., 2010b). Our GO data for methylation-regu-
lated diﬀerentially expressed genes reveals that an UCB-MNC speciﬁc
Fig. 6. Inhibiting DNMT activity aﬀects the transcriptional levels of UCB-MNC enriched genes through decreasing DNA methylation. (A) qRT-PCR (left) and RT-PCR (right) analyses of
mRNA levels of DNMT3A, DNMT3B, and DNMT1 in UCB-MNCs and OECs. (B) We treated OECs with 50% acetic acid (Con), 5′-aza-2′-cytidine dissolved in 50% acetic acid (5′-aza-dc;
10 μm, 7 days, 24 h) followed by qRT-PCR analysis of MNC-enriched genes (CD74, VAV1, ITGAX, CARD9, LGALS3BP, P2RY6, NCF4, FCER1G, and PTAFR). CXCR4 served as the negative
control. (A–B) qPCR data were normalized to the levels of GAPDH mRNA. *p < 0.1, **p < 0.01, ***p < 0.001. ns, not signiﬁcant. (C) Bisulﬁte sequencing of speciﬁc CpGs within the
VAV1 promoter of OECs treated with the control and 5′-aza-dc. Open and ﬁlled circles indicate unmethylated and methylated CpGs, respectively.
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gene cluster is hyper-methylated in OECs and was highly enriched
immune response-associated functions, reﬂecting the hematopoietic
character of mononuclear cells compared with terminally diﬀerentiated
ECs. In contrast, OEC-enriched hypomethylated genes were associated
with developmental process and angiogenesis, indicating that speciﬁc
UCB-MNC and OEC phenotypes are regulated by DNA methylation
during diﬀerentiation.
We conﬁrmed the negative correlation of promoter methylation and
gene expression. Our work highlights representative genes included in
GO biological process categories. CD74 is a receptor for the proin-
ﬂammatory cytokine macrophage migration inhibitory factor (Schwartz
et al., 2009). This ligand/receptor complex activates CXCR4 signaling
pathways, which is a marker of UCB-MNCs, which trigger the synthesis
and secretion of proinﬂammatory factors and cell adhesion molecules
(Doring et al., 2014). VAV1 is a guanine nucleotide exchange factor for
Rho/Rac GTPase and is speciﬁcally expressed by cells of the hemato-
poietic system. The VAV1 promoter is fully demethylated in lympho-
cytes where VAV1 is normally expressed, and VAV1 controls hemato-
poiesis through binding to the hematopoietic transcription factor MYB
(Ilan and Katzav, 2012). We determined that these UCB-MNC speciﬁc
enriched genes were silenced by hypermethylation during diﬀerentia-
tion.
Conversely, ECSCR and MCAM play crucial roles in ECs. ECSCR and
MCAM are cell-surface proteins expressed by ECs, which play roles in
EC migration, apoptosis, and proliferation (Verma et al., 2010; Jouve
et al., 2015). Their function is associated with VEGF-triggered sig-
naling. Loss of ECSCR from primary ECs reduces tyrosine phosphor-
ylation of the VEGF receptor 2/kinase insert domain receptor (KDR)
(Verma et al., 2010). Further, MCAM deﬁciency decreases the expres-
sion of VEGFR-2/Ve-cadherin and alters focal adhesion kinase (FAK)
activation in response to VEGF (Jouve et al., 2015). Our RT-PCR and
bisulﬁte sequencing results show that OEC-enriched genes, particularly
those that are angiogenesis-related, are hypomethylated state with in-
creased expression levels during diﬀerentiation.
Analyzing microarrays to compare the expression of our focus genes
in other EC lineages such as HUVEC, HUAEC, and LEC, these data are
consistent with our previous ﬁnding on mRNA sequencing proﬁling
(Supplementary Fig. 4). Methylation of the promoters of EC marker
genes encoding eNOS, vWF, CD31, and VE-cadherin is reduced in
HUVECs compared with the non-EC cell type AoVSMC (Shirodkar et al.,
2013; Ohtani et al., 2011). Similarly, we detected hypomethylation of
these genes in OECs. However, the genes encoding vWF, CD31, and VE-
cadherin were also hypomethylated in UCB-MNCs. Moreover, when we
compared DNA methylation of UCB-MNC derived mesenchymal stem
Fig. 7. DNA demethylase directly aﬀects the transcriptional levels of OEC-enriched genes. (A) After exposure of UCB-MNCs to 5′-aza-dc (10 μmol/l) every 2 days for 14 days, relative
expression levels of OEC-enriched genes (ECSCR,MCAM, PGF, and ARHEGF15) were assessed by qRT-PCR. (B) The mRNA levels of DNA demethylase family genes TET1, TET2, and TET3
in UCB-MNCs and OECs were analyzed using qRT-PCR (left) and RT-PCR (right). (C) OECs were transfected with a control shRNA or shRNA-TET1 and shRNA-TET2 lentivirus. After
culture for 14 days, relative mRNA levels of OEC-enriched genes (ECSCR, PGF, MDFI, CTHRC1, and DOCK9) were analyzed using qRT-PCR. All results were normalized to GAPDH mRNA
levels. **p < 0.01, ***p < 0.001 (t-test). ns, not signiﬁcant. VEGFR2 mRNA served as the negative control.
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cells (MSCs) and OECs, the genes encoding eNOS, CD31, and VE-cad-
herin were hypermethylated in MSCs, indicating that the methylation
of these EC-enriched genes may diﬀer between ECs and non-ECs, but
these patterns do not always occur during UCB-MNC to OEC diﬀer-
entiation.
We show here the reversibility of DNA methylation, which em-
phasizes the importance of DNA methylation regulators in gene ex-
pression. Inhibition of promoter methylation induced the demethyla-
tion and reactivation of UCB-MNC speciﬁc immune-related genes in
OECs, in which the gene was hypermethylated. However, certain genes
were not reactivated. Our GO analysis reveals that TLR8, which encodes
a member of the Toll-like receptor family, was enriched in immune-
related processes (Takeda and Akira, 2005). TLR8 was not reactivated
in nonexpressing cells (OECs) after inhibiting DNMTase activity, al-
though bisulﬁte sequencing showed reduced methylation of TLR8,
suggesting the possibility that gene activation requires transcription
factors, although DNA methylation is decreased. In the hypomethylated
gene set, we detected reduced expression of certain genes related to
angiogenesis, such as PGF, ECSCR, CTHRC1, and DOCK9 in long-term
cultures of OECs after inhibiting the DNA demethylases TET1 and TET2.
These data are consistent with the possibility that DNA demethylase
promotes the hydroxymethylation of the promotor of these genes, fa-
cilitating demethylation and promoting transcription. In contrast, we
observed that TET1 and TET2 depletion did not aﬀect the expression of
other genes such as MCAM and ARHGEF15. Our data suggest that the
MCAM and ARHGEF15 promoter is normally silenced by DNA methy-
lation, and these demethylations using 5′-aza-dc reactivated the ex-
pressions in UCB-MNCs. However, it is clear that MCAM and
ARHGEF15 expressions were aﬀected by DNA methylation, although
further studies are required to ascertain whether TET directly binds to
MCAM, ARHGEF15, or other genes and aﬀects the expression of these
genes.
Altogether, the data suggest that DNA methylation is a speciﬁc
factor that controls the cell-type expression of speciﬁc genes during
UCB-MNC to OEC diﬀerentiation, and the changes induced by
DNMTases and demethylase directly regulated gene expression and
were maintained in terminally diﬀerentiated cells.
5. Conclusion
DNA methylation and demethylation are crucial regulators of gene
expression during cell diﬀerentiation. Understanding of interrelation
between DNA methylation and gene expression provide a new insight
that epigenetic mechanisms are involved in UCB-MNC to OEC diﬀer-
entiation. Here, we proﬁled global changes of promoter methylation
and gene expression during the diﬀerentiation of UCB-MNCs to OECs
and identiﬁed a number of genes with negative correlation between
methylation and gene expression. Functional analysis revealed that the
characteristics of UCB-MNCs were silenced by hypermethylation and
the characteristics of OECs were activated with hypomethylation during
diﬀerentiation. Further, the reversibility of DNA methylation empha-
sizes the importance of DNA methylation regulator in gene expression.
Our ﬁndings suggest that DNA methylation is a speciﬁc factor that
controls the cell-type expression of speciﬁc genes during UCB-MNC to
OEC diﬀerentiation.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.gene.2017.09.006.
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